abstract |
The present invention relates to fusion proteins and to the use of fusion proteins (or genetic constructs or vectors encoding such fusion proteins) in vaccination against viral infection. The present invention extends to pharmaceutical compositions comprising such fusion proteins or constructs for the prevention and treatment of viral infections, and methods and uses thereof. |